Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Allogeneic Cellular Vaccine 1650-G

Known as: 1650-G, 1650-G Vaccine, 1650G 
A pluripotent, allogeneic, tumor cell vaccine composed of irradiated tumor cells from the non-small cell lung cancer (NSCLC) cell line 1650 and the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract A fetus of Chinese descent presented with ultrasound features of anemia at 20 weeks’ gestation. Father had low a mean… Expand
2011
2011
Introduction: Cancer immunotherapy is a conceptually attractive since it is highly specific and can deal with disseminated… Expand
2005
2005
Introduction: Neonatal networks and dedicated intensive care retrieval systems are evolving in the United Kingdom. Early back… Expand
Review
2000
Review
2000
BACKGROUND This section is under preparation and will be included in the next issue. OBJECTIVES In preterm or low birth weight… Expand
1995
1995
Abstract : Platelet dysfunction and increased fibrinolysis are the most important etiologic factors in the hemostatic defect… Expand
  • table 2
Highly Cited
1970
Highly Cited
1970
Abstract Several reports have implicated an adherent cell population—enriched in macrophages—in the in vitro lymphocyte response… Expand